🇺🇸 FDA
Patent

US 11865157

Compositions and methods of targeting cancer stem cells

granted A61KA61K31/357A61K31/381

Quick answer

US patent 11865157 (Compositions and methods of targeting cancer stem cells) held by The Board of Regents of the University of Texas System expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/357, A61K31/381, A61K38/04, A61K38/08